V

L

VANLEMMENS , L.

Last name: VANLEMMENS

First name: L.

May 2018 (v1)

Journal article

Metadata-only

Endocrine therapy or chemotherapy as first-line therapy in hormone receptor–positive HER2-negative metastatic breast cancer patients

Jacquet, E. Lardy-Cléaud, A. Pistilli, B.

BACKGROUND:For hormone receptor-positive (HR+) human epidermal growth factor receptor 2 (HER2-) negative metastatic breast cancer (MBC), international guidelines recommend endocrine therapy as first-line treatment, except in case of 'visceral crisis'. In the latter case, chemotherapy is preferred. Few studies have compared these two strategies....

Uploaded on: December 4, 2022
May 2018 (v1)

Journal article

Metadata-only

5-year overall survival after early breast cancer diagnosed during pregnancy: A retrospective case-control multicentre French study

Ploquin, A. Pistilli, B. Tresch, E.

BACKGROUND:Breast cancer diagnosed during pregnancy (BCP) is rare, but the prevalence is expected to rise. Long-term follow-up data regarding this clinically challenging condition are scarce. The main objective of this multicentre case-control French study was to compare the survival between pregnant patients and matched...

Uploaded on: December 4, 2022